Lack of concordance between the F-18 fluoromisonidazole PET and the F-18 FDG PET in human glioblastoma

Henri De Clermont, Aymeri Huchet, Frédéric Lamare, Annalisa Rivière, Philippe Fernandez
Clinical Nuclear Medicine. 2011-12-01; 36(12): e194-e195
DOI: 10.1097/RLU.0b013e3182335e20


Lire sur PubMed

---

1. Clin Nucl Med. 2011 Dec;36(12):e194-5. doi: 10.1097/RLU.0b013e3182335e20.

Lack of concordance between the F-18 fluoromisonidazole PET and the F-18 FDG PET
in human glioblastoma.

De Clermont H(1), Huchet A, Lamare F, Rivière A, Fernandez P.

Author information:
(1)Service de Médecine Nucléaire, Hôpital Pellegrin, CHU de Bordeaux, Bordeaux,
France.

DOI: 10.1097/RLU.0b013e3182335e20
PMID: 22064107 [Indexed for MEDLINE]

Auteurs Bordeaux Neurocampus